Triglycerides

 
Home > Lowering Triglycerides Information > Lowering Triglycerides News

Lowering Triglycerides News

  • Studies Refine Obesity's Risk for Heart Troubles Monday, August 11, 2008 @ 5:31PMCopyright © 2008 ScoutNews LLC. All rights reserved. MONDAY, Aug. 11 (HealthDay News) -- Some obese people don't seem to be at increased risk for heart disease, while some normal-weight people have a number of heart disease risk factors, according to two studies.
  • Review of Science Finds Soyfoods Lower Cholesterol Thursday, August 7, 2008 @ 3:14PM A recent study by Dr. Alicia Thorpe confirms soyfoods lower total cholesterol, even though the author found the reduction in LDL cholesterol was not significant.
  • Genzyme And Isis Begin Second Phase 3 Trial Of Mipomersen Thursday, August 7, 2008 @ 5:18AMGenzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that they have begun a phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH), a genetic disorder that causes exceptionally high levels of LDL cholesterol.
  • Treating High Cholesterol Wednesday, August 6, 2008 @ 4:33PMFrom diet to exercise to medication, what's the right way for you to treat your high cholesterol?
  • Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen Wednesday, August 6, 2008 @ 2:07PM Genzyme Corp. and Isis Pharmaceuticals, Inc. today announced that they have begun a phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia , a genetic disorder that causes exceptionally high levels of LDL cholesterol.
  • Exercise Pill is No Replacement for Actual Exercise Says Expert on ‘Inactivity’ Tuesday, August 5, 2008 @ 6:59PMAug. 5, 2008 – The “exercise pill” hyped by a report from researchers at the Salk Institute of Biological Studies cannot be considered a replacement for exercise, says Frank Booth, a University of Missouri expert on the science of inactivity.
  • Karo Bio Announces Successful Phase II Study With Eprotirome In Combination With Statin Tuesday, August 5, 2008 @ 5:17AMKaro Bio has successfully completed a 12 week phase IIb study of eprotirome (KB2115) given to patients with dyslipidemia (elevated blood lipids). These patients were already on statin treatment. Data show that eprotirome induced a statistically significant and clinically relevant lowering of serum LDL-cholesterol, triglycerides and lipoprotein (a) and was safe and well tolerated.
  • Karo Bio Shares Have Record Gain After Cholesterol Drug Study Monday, August 4, 2008 @ 4:37AMAug. 4 (Bloomberg) -- Karo Bio AB , the Swedish drugmaker developing an experimental cholesterol drug, had a record increase in Stockholm trading after a study showed the treatment helped patients taking medicines such as Pfizer Inc.'s Lipitor.
  • Lifestyle Factors Contribute To Lowering And Raising Risk Of Alzheimer's Disease Thursday, July 31, 2008 @ 6:10AMA new study suggests that those who are unmarried or not living with a partner in midlife could have an increased risk of developing Alzheimer's disease, according to research reported today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008), in Chicago.
  • Amarin Proceeding To Phase 3 With AMR101 For Hypertriglyceridemia Wednesday, July 23, 2008 @ 7:13AMAmarin Corporation plc (NASDAQ: AMRN) announced that the Company recently met with officials at the U.S. Food and Drug Administration (FDA) to discuss the Company's plans to develop AMR101 for the treatment of hypertriglyceridemia. Following these discussions, the Company is proceeding to Phase 3 with AMR101 in hypertriglyceridemia. Dr.
  • Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia Tuesday, July 22, 2008 @ 8:48AM Amarin Corporation plc today announced that the Company recently met with officials at the U.S. Food and Drug Administration to discuss the Company's plans to develop AMR101 for the treatment of hypertriglyceridemia.
  • VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels And Atherosclerosis Tuesday, July 22, 2008 @ 6:10AMUsing the VAP Cholesterol Test from Atherotech, researchers have identified a link between adiponectin and heart disease progression. The information could help physicians trying to pinpoint the most effective cholesterol and heart disease risk-lowering treatments in at-risk patients.
  • HealthWatch: Foods To Lower Your Cholesterol Monday, July 21, 2008 @ 6:46PMIt may seem backwards, but people trying to lower their cholesterol may benefit by adding to their diet, rather than taking away. There's a great deal of attention paid to what not to eat when you're watching your cholesterol, and for good reason. But what you eat doesn't only raise your cholesterol – in some cases it can lower it.
  • Women’s Heart Health 101 Thursday, July 17, 2008 @ 7:38PMSurprise, cholesterol isn't all bad. Your body uses it to make hormones, vitamin D, and substances that aid digestion. But that doesn't mean you should make a run for the turkey bacon. That's because your body makes all the cholesterol it needs on its own, without any extra-fatty foods eaten by you.
  • Examine the Opportunities with Dyslipidemia in Cardiovascular Risk Reduction Thursday, July 17, 2008 @ 5:38AM DUBLIN, Ireland----Research and Markets has announced the addition of the "Dyslipidemia: Opportunities in Cardiovascular Risk Reduction" report to their offering.
  • Diet Plans Produce Similar Results Wednesday, July 16, 2008 @ 6:02PMCopyright © 2008 ScoutNews LLC. All rights reserved. WEDNESDAY, July 16 (HealthDay News) -- New research shows that Mediterranean and low-carb diets are just as good and just as safe as the low-fat diet often prescribed by doctors, a revelation that should give people more choices in eating well.
  • Cholesterol kids: Rx or exercise? Wednesday, July 16, 2008 @ 10:06AMYou might be wondering if your kid should be taking a statin
  • Game of Hearts Wednesday, July 16, 2008 @ 12:00AM Predicting complex nuclear-attack scenarios used to be the, er, bomb in computer modeling. Now it's complicated human systems that test new drugs and forecast, in a first-ever test, one person's cardiac fate.
  • Can fish oil replace statins in lowering cholesterol? Thursday, July 10, 2008 @ 5:12AMWashington, July 10 : With 40 percent of heart patients who take cholesterol-lowering statins stopping the drug in less than a year, doctors have been on the lookout for an alternative.
  • Lowering Blood Cholesterol With Fish Oil And Red Yeast Rice Instead Of Statins Thursday, July 10, 2008 @ 12:22AMResearchers have examined whether an alternative approach to treating high blood cholesterol may provide an effective treatment option for patients who are unable or unwilling to take statins. The researchers noted that there was a reduction in LDL cholesterol levels in both the statin group and the fish oil alternative treatment group. Members of the alternative therapy group also had a ...
  • Industry Insider: Statin spending rises to good levels Thursday, July 3, 2008 @ 12:53AMSpending on statins, drugs used to reduce artery-clotting cholesterol, jumped to almost $20 billion between 2000 and 2005, from $8 billion, according to a report from the federal Agency for Healthcare Research and Quality.
  • FAU Researcher reports statin research Wednesday, July 2, 2008 @ 5:20PMIn the June issue of the American Journal of Cardiovascular Drugs, Florida Atlantic University researcher Dr. Charles H. Hennekens has written the lead article in a discussion of the strengths and limitations of fixed-dose combination therapy with statins.
  • Study shows 150 percent jump in statin use Wednesday, June 25, 2008 @ 3:07PMWASHINGTON (Reuters) - Use of cholesterol-lowering drugs called statins rose by 156 percent between 2000 and 2005, with spending jumping from $7.7 billion to $19.7 billion, the U.S. Agency for Healthcare Research and Quality reported on Wednesday.
  • Metabasis Announces Promising Results from Its Phase 1b Clinical Trial for MB07811, Its Novel Product Candidate for ... Thursday, June 19, 2008 @ 7:30AM SAN DIEGO----Metabasis Therapeutics, Inc. announced today the results of its 14-day, Phase 1b multiple-dose clinical trial in subjects with mild hypercholesterolemia, which showed that MB07811 was safe and well tolerated across the seven doses tested, ranging from 0.25 mg up to 40 mg.
  • Metabolex Completes Patient Enrollment In Phase 2 Trial Of MBX-8025 For Treatment Of Dyslipidemia Tuesday, June 17, 2008 @ 5:04AMMetabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has completed enrollment in a 180-patient Phase 2 trial of MBX-8025 in overweight or obese patients with high cholesterol and triglycerides.
  • Orexigen(R) Therapeutics to Discuss Two Advanced-Stage Obesity Products That Target the Brain's Critical Role in ... Thursday, June 12, 2008 @ 7:01AM SAN DIEGO----Orexigen® Therapeutics, Inc. , a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, is scheduled to present an overview of its novel understanding of the current obesity epidemic.
  • Turn Your Kitchen Into a Clinic Monday, June 9, 2008 @ 12:14PMJohn La Puma offers tips on culinary medicine after cowriting a new book.
  • Are You Getting Enough Heart Protecting Nutrients in Your Diet? Monday, June 9, 2008 @ 10:09AM(ARA) - If you have a family history of what's often referred to as "The Silent Killer," you owe it to yourself to take steps to protect your health.
  • Hollis-Eden Pharmaceuticals Reports Additional Positive Data from Phase I/II Clinical Trial with TRIOLEX(TM) ... Monday, June 9, 2008 @ 7:00AM SAN DIEGO----Hollis-Eden Pharmaceuticals, Inc. today announced additional positive interim data from its on-going Phase I/II clinical trial with its investigational oral drug candidate TRIOLEX , supporting the potential benefit of a novel anti-inflammatory approach to improving insulin sensitivity in patients with type 2 diabetes.
  • Results Published Of ACCORD Clinical Trial Monday, June 9, 2008 @ 5:12AMIntensively targeting blood sugar to near-normal levels in adults with type 2 diabetes at especially high risk for heart attack and stroke does not significantly reduce the risk of major cardiovascular events, such as fatal or nonfatal heart attacks or stroke, but increases risk of death, compared to standard treatment.
  • San Francisco Saturday, June 7, 2008 @ 1:21PMSAN FRANCISCO , June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ), and Alkermes, Inc. (Nasdaq: ALKS ) announced results from a 30-week study that compared the efficacy of exenatide once weekly, a long-acting release formulation of exenatide, to BYETTA(R) (exenatide) injection.
  • Low HDL cholesterol from gene variation not associated with increased risk of ischemic heart disease Tuesday, June 3, 2008 @ 5:35PMLower levels of high-density lipoprotein (HDL) cholesterol due to a gene mutation is not associated with an increased risk of ischemic heart disease, according to a study in the June 4 issue of JAMA.
  • Ischemic Heart Disease Not Associated With Low HDL Levels From Gene Variation Tuesday, June 3, 2008 @ 5:10PMA paper published in the June 4 issue of JAMA hasshown that patients who have lower levels of high-density lipoprotein(HDL) cholesteroldue to a gene mutation do not have an increased risk of ischemic heartdisease.Low plasma levels of HDL - also known as the "good" cholesterol - havebeen linked to an increased risk of ischemic heart disease (IHD) inseveral previous studies.
  • Separating cholesterol facts from fiction Tuesday, June 3, 2008 @ 3:43AMThe good, the bad and the total cholesterol: How much do you know about the effects on your arteries? Too much of the wrong kinds can increase your risk for heart disease. But boosting your level of the right type with healthier lifestyle habits can be protective.
  • Studies Define Type 2 Diabetes Risk Factors In Women, Adolescents Friday, May 30, 2008 @ 6:10PMThe risk of developing type 2 diabetes in women is significantly increased as a result of either low cardiorespiratory fitness or higher Body Mass Index (BMI), and a combination of the two increases the risk the most, according to a long-term study presented at the 55th Annual Meeting of the American College of Sports Medicine (ACSM).
  • San Francisco Friday, May 30, 2008 @ 3:20PMCOLLEGEVILLE, Pa. ( Map ) - COLLEGEVILLE, Pa. , May 30 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced the initiation of the INTORACT (INvestigation of TORISEL and Avastin Combination Therapy) study, a worldwide randomized, open-label, phase 3b study comparing TORISEL(R) (temsirolimus) plus Avastin(R) (bevacizumab) versus Avastin plus ...
  • Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced ... Friday, May 30, 2008 @ 2:04PM Wyeth Pharmaceuticals, a division of Wyeth , today announced the initiation of the INTORACT study, a worldwide randomized, open-label, phase 3b study comparing TORISEL plus Avastin versus Avastin plus interferon-alfa for first-line treatment of patients with advanced renal cell carcinoma .
  • Nutrition Wise: Greek Yogurt, Sterols and Stanols, Vitamins and Calories Friday, May 30, 2008 @ 10:10AMBy Karen Collins, MS, RD, CDN - Q: How does Greek yogurt compare to regular yogurt in terms of nutrition? Q: What are the "sterols" and "stanols" that I now see added to foods? Q: Do vitamins have calories?
  • What Have You Done for Your Heart Health Lately? Thursday, May 29, 2008 @ 3:30PM(ARA) - If you have a family history of what's often referred to as "The Silent Killer," you owe it to yourself to take steps to protect your health.
  • A walnut can do... what? Thursday, May 29, 2008 @ 12:18PMI know a number of people whose consumption of nuts only includes almonds. Almonds are great, but there are many benefits to consuming several types of nuts.
  • Turn Your Kitchen Into a Clinic Tuesday, May 20, 2008 @ 2:08PMJohn La Puma offers tips on culinary medicine after cowriting a new book.
  • YOU ARE HERE: Friday, May 16, 2008 @ 8:58AMHIV/HCV co-infected individuals with higher “bad” LDL cholesterol levels are more likely to respond successfully to anti-hepatitis C treatment than those with lower levels of LDL. While several previous studies had shown higher LDL to predict better treatment response in hepatitis C-monoinfected individuals, this retrospective study – reported in the May 11 issue of AIDS – is the first to show a ...
  • A better treatment for heart diseases Friday, May 9, 2008 @ 1:44PMMANILA, Philippines—While today’s cardiologists enjoy an impressive array of options to treat their heart patients, it seems the relatively less expensive and uncomplicated regimen to reverse atherosclerosis (narrowing of the arteries) could prove to be the most effective, long-term solution against heart disease.
  • Soy foods: dear to your heart Friday, May 9, 2008 @ 12:49PMSoybeans have been consumed in various forms for thousands of years. Issues today bring soy beyond its traditional uses in foods. There are now sound medical reasons to include soy products in your diet every day.
  • NourishLife - In Conjunction with National Stroke Month, NourishLife is Giving Away Free Samples of Omega-3 to Reduce ... Friday, May 2, 2008 @ 3:32AM NourishLife is launching an awareness campaign by giving away free samples of its omega-3 supplement Cardio to warn Americans of the risk of stroke. (PRWeb May 2, 2008) Read the full story at http://www.prweb.com/releases/2008/05/prweb910744.htm
  • NourishLife - In Conjunction with National Stroke Month, NourishLife is Giving Away Free Samples of Omega-3 to Reduce ... Friday, May 2, 2008 @ 3:00AM NourishLife is launching an awareness campaign by giving away free samples of its omega-3 supplement Cardio to warn Americans of the risk of stroke.
  • eFoodSafety s Cinnechol(TM) Positioned to Make In-Roads in Cholesterol . Market Saturday, April 26, 2008 @ 1:21AMMarket 24/04/2008 13:35:00 Business Wire Cholesterol-lowering drugs comprise the largest drugs class in the U.S., amounting to over $20 billion annually.
  • Merck's Tredaptive & Janumet get EMA recommendation for approval in EU Friday, April 25, 2008 @ 11:38PMThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended Merck's two medicines for marketing approval in the European Union (EU).
  • FYI: Keeping Cholesterol Down Without Meds Friday, April 25, 2008 @ 9:30AMThere's new scrutiny of statins, which are the most popular prescription drug ever that's been marketed as a cholesterol-lowering medication. Medical experts suggest ways to lower your cholesterol without drugs - making simple lifestyle changes
  • VLDL cholesterol: What is it? Friday, April 25, 2008 @ 3:12AMVery-low-density lipoprotein (VLDL) cholesterol is one of the three major types of lipoproteins. The other two are high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol. Each type contains a mixture of cholesterol, protein and triglyceride, but in varying amounts.